Literature DB >> 29204754

The Na+/Cl--Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB0,+): Emerging Roles in Multiple Diseases and Therapeutic Potential for Treatment and Diagnosis.

Mohd Omar F Sikder1, Shengping Yang1, Vadivel Ganapathy1, Yangzom D Bhutia2.   

Abstract

Amino acids are essential building blocks of all mammalian cells, and amino acid transporters play a vital role in transporting them into cells and their further distribution among the various cellular compartments. There are ~ 430 known transporters in the solute-linked carrier (SLC) gene family, divided into 52 distinct families. Eleven of these gene families contain one or more amino acid transporters. These transporters differ significantly from each other in terms of substrate specificity, ion dependence, and energetics. Given the variety of roles they fulfill in human physiology, it is not surprising that a number of diseases are associated with the malfunction of these transporters. In particular, as amino acids are critical for cell growth, survival, and proliferation, the role of amino acid transporters in cancer is gaining increasing attention in recent years. The present review primarily focuses on one particular amino acid transporter, SLC6A14 (also known as ATB0,+), with regard to its relevance to specific diseases, including cancer, and the molecular mechanisms underlying the disease-related alterations in the expression of the transporter. Furthermore, the review highlights the possible utility of this transporter in drug delivery and also its therapeutic potential for the treatment and diagnosis of cancer.

Entities:  

Keywords:  SLC6A14; cancer; colitis; cystic fibrosis; fertility; glutamine addiction; mTORC1; microRNAs; obesity

Mesh:

Substances:

Year:  2017        PMID: 29204754     DOI: 10.1208/s12248-017-0164-7

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  89 in total

Review 1.  Glutamine transporters in mammalian cells and their functions in physiology and cancer.

Authors:  Yangzom D Bhutia; Vadivel Ganapathy
Journal:  Biochim Biophys Acta       Date:  2015-12-24

2.  Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with Coptidis rhizoma aqueous extract.

Authors:  Meifen Zhu; Ning Wang; Sai-Wah Tsao; Man-Fung Yuen; Yigang Feng; Thomas S K Wan; Kwan Man; Yibin Feng
Journal:  Exp Ther Med       Date:  2010-11-19       Impact factor: 2.447

3.  Transporter occluded-state conformation-induced endocytosis: Amino acid transporter ATB0,+-mediated tumor targeting of liposomes for docetaxel delivery for hepatocarcinoma therapy.

Authors:  Qiuhua Luo; Ping Gong; Mengchi Sun; Longfa Kou; Vadivel Ganapathy; Yongkui Jing; Zhonggui He; Jin Sun
Journal:  J Control Release       Date:  2016-11-01       Impact factor: 9.776

4.  Gene expression alterations in ulcerative colitis patients after restorative proctocolectomy extend to the small bowel proximal to the pouch.

Authors:  Henit Yanai; Shay Ben-Shachar; Liran Baram; Hofit Elad; Gilad Gitstein; Eli Brazowski; Hagit Tulchinsky; Metsada Pasmanik-Chor; Iris Dotan
Journal:  Gut       Date:  2014-06-30       Impact factor: 23.059

5.  Ferroptosis as a p53-mediated activity during tumour suppression.

Authors:  Le Jiang; Ning Kon; Tongyuan Li; Shang-Jui Wang; Tao Su; Hanina Hibshoosh; Richard Baer; Wei Gu
Journal:  Nature       Date:  2015-03-18       Impact factor: 49.962

Review 6.  Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.

Authors:  Vadivel Ganapathy; Muthusamy Thangaraju; Puttur D Prasad
Journal:  Pharmacol Ther       Date:  2008-11-01       Impact factor: 12.310

Review 7.  Rethinking the Warburg effect with Myc micromanaging glutamine metabolism.

Authors:  Chi V Dang
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

8.  Targeting glioma cells in vitro with ascorbate-conjugated pharmaceutical nanocarriers.

Authors:  Stefano Salmaso; Juan S Pappalardo; Rupa R Sawant; Tiziana Musacchio; Karen Rockwell; Paolo Caliceti; Vladimir P Torchilin
Journal:  Bioconjug Chem       Date:  2009-12       Impact factor: 4.774

9.  HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5.

Authors:  Ainara Elorza; Inés Soro-Arnáiz; Florinda Meléndez-Rodríguez; Victoria Rodríguez-Vaello; Glenn Marsboom; Guillermo de Cárcer; Bárbara Acosta-Iborra; Lucas Albacete-Albacete; Angel Ordóñez; Leticia Serrano-Oviedo; Jose Miguel Giménez-Bachs; Alicia Vara-Vega; Antonio Salinas; Ricardo Sánchez-Prieto; Rafael Martín del Río; Francisco Sánchez-Madrid; Marcos Malumbres; Manuel O Landázuri; Julián Aragonés
Journal:  Mol Cell       Date:  2012-10-25       Impact factor: 17.970

10.  Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis.

Authors:  Harriet Corvol; Scott M Blackman; Pierre-Yves Boëlle; Paul J Gallins; Rhonda G Pace; Jaclyn R Stonebraker; Frank J Accurso; Annick Clement; Joseph M Collaco; Hong Dang; Anthony T Dang; Arianna Franca; Jiafen Gong; Loic Guillot; Katherine Keenan; Weili Li; Fan Lin; Michael V Patrone; Karen S Raraigh; Lei Sun; Yi-Hui Zhou; Wanda K O'Neal; Marci K Sontag; Hara Levy; Peter R Durie; Johanna M Rommens; Mitchell L Drumm; Fred A Wright; Lisa J Strug; Garry R Cutting; Michael R Knowles
Journal:  Nat Commun       Date:  2015-09-29       Impact factor: 14.919

View more
  19 in total

1.  Amino Acids in Cell Signaling: Regulation and Function.

Authors:  Sudikshya Paudel; Guoyao Wu; Xiaoqiu Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Flux coupling, not specificity, shapes the transport and phylogeny of SLC6 glycine transporters.

Authors:  Bastien Le Guellec; France Rousseau; Marion Bied; Stéphane Supplisson
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-03       Impact factor: 12.779

3.  Editorial: Metabolite and Nutrient Transporters in Cancer-Cell Metabolism: Role in Cancer Progression and Metastasis.

Authors:  Vadivel Ganapathy; Sebastian Haferkamp; Eric K Parkinson; Maria E Mycielska
Journal:  Front Cell Dev Biol       Date:  2022-04-25

4.  SLC6A14 facilitates epithelial cell ferroptosis via the C/EBPβ-PAK6 axis in ulcerative colitis.

Authors:  Yanjun Chen; Wenying Yan; Yuqi Chen; Jinghan Zhu; Jiayu Wang; Haiyan Jin; Hongya Wu; Guangbo Zhang; Shenghua Zhan; Qinhua Xi; Tongguo Shi; Weichang Chen
Journal:  Cell Mol Life Sci       Date:  2022-10-22       Impact factor: 9.207

5.  PATs and SNATs: Amino Acid Sensors in Disguise.

Authors:  Shih-Jung Fan; Deborah C I Goberdhan
Journal:  Front Pharmacol       Date:  2018-06-19       Impact factor: 5.810

6.  y+LAT1 and y+LAT2 contribution to arginine uptake in different human cell models: Implications in the pathophysiology of Lysinuric Protein Intolerance.

Authors:  Bianca Maria Rotoli; Amelia Barilli; Rossana Visigalli; Francesca Ferrari; Valeria Dall'Asta
Journal:  J Cell Mol Med       Date:  2019-11-09       Impact factor: 5.310

Review 7.  SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine-Glycine-One-Carbon Pathways in Cancer.

Authors:  Tyler Sniegowski; Ksenija Korac; Yangzom D Bhutia; Vadivel Ganapathy
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-04

8.  SLC6A14, a Na+/Cl--coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling.

Authors:  Mohd O F Sikder; Sathish Sivaprakasam; Timothy P Brown; Muthusamy Thangaraju; Yangzom D Bhutia; Vadivel Ganapathy
Journal:  Biochem J       Date:  2020-04-30       Impact factor: 3.857

9.  Trafficking of the amino acid transporter B0,+ (SLC6A14) to the plasma membrane involves an exclusive interaction with SEC24C for its exit from the endoplasmic reticulum.

Authors:  Vasylyna Kovalchuk; Łukasz Samluk; Barbara Juraszek; Dominika Jurkiewicz-Trząska; Sonja Sucic; Michael Freissmuth; Katarzyna A Nałęcz
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-11-14       Impact factor: 4.739

Review 10.  Membrane Transporters for Amino Acids as Players of Cancer Metabolic Rewiring.

Authors:  Mariafrancesca Scalise; Lara Console; Filomena Rovella; Michele Galluccio; Lorena Pochini; Cesare Indiveri
Journal:  Cells       Date:  2020-09-03       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.